# Emodin-8-O-β-D-glucoside

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/emodin-8-o-d-glucoside
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-29
**Evidence Score:** 2 / 10
**Category:** Compound
**Also Known As:** Emodin 8-O-glucoside, Emodin-8-glucoside, 8-O-β-D-glucopyranosylemodin, Emodin 8-β-D-glucoside, Chrysophanol-1-methyl ether-8-O-β-D-glucoside, EMO-8-Glu, Hydroxyanthraquinone glycoside

## Overview

Emodin-8-O-β-D-glucoside is an anthraquinone glycoside derived from plants such as Rheum and Polygonum species, formed by the glucosylation of emodin at the 8-hydroxyl position. It exerts biological activity primarily through activation of PPARα/γ and AMPK signaling pathways, 5-HT1B [serotonin](/ingredients/condition/mood) receptor agonism, and direct [antiviral](/ingredients/condition/immune-support) enzyme inhibition.

## Health Benefits

• Exhibits antiviral effects through in vitro studies, suggesting potential in viral inhibition. [4,8]
• Acts as a 5-HT1B agonist, which may influence [serotonin](/ingredients/condition/mood) pathways. [4,7]
• Activates PPARα/γ and AMPK pathways, contributing to various biological activities. [4,7]
• Demonstrates enzyme inhibition properties in animal models. [1,8]
• Possesses [immunomodulatory](/ingredients/condition/immune-support) effects, as evidenced in preclinical studies. [4]

## Mechanism of Action

Emodin-8-O-β-D-glucoside activates peroxisome proliferator-activated receptors PPARα and PPARγ alongside AMP-activated protein kinase (AMPK), modulating lipid [metabolism](/ingredients/condition/weight-management) and cellular energy homeostasis. It acts as an agonist at the 5-HT1B [serotonin](/ingredients/condition/mood) receptor, potentially influencing [neurotransmitter](/ingredients/condition/cognitive) signaling and [vascular tone](/ingredients/condition/heart-health). Additionally, it demonstrates inhibitory activity against viral enzymes and select metabolic enzymes, with in vitro data suggesting interference with viral replication machinery.

## Clinical Summary

Current evidence for emodin-8-O-β-D-glucoside is largely limited to in vitro cell-based assays and preclinical animal models, with no published randomized controlled human clinical trials specifically isolating this compound. In vitro studies have demonstrated [antiviral](/ingredients/condition/immune-support) activity, PPARα/γ activation, and AMPK pathway engagement, but quantified effect sizes and therapeutic concentrations have not been validated in human subjects. Animal model data suggest potential metabolic and [anti-inflammatory](/ingredients/condition/inflammation) outcomes, though translational relevance remains uncertain. Overall, the evidence base is preliminary and insufficient to establish clinical recommendations or effective human dosages.

## Nutritional Profile

Emodin-8-O-β-D-glucoside (also known as emodin-8-glucoside) is not a nutritional substance but rather a bioactive anthraquinone glycoside. It is the 8-O-β-D-glucopyranoside derivative of emodin (1,3,8-trihydroxy-6-methylanthraquinone). Molecular formula: C₂₁H₂₀O₁₀; molecular weight: ~432.38 g/mol. It is found naturally in several medicinal plants, notably Rheum palmatum (rhubarb), Polygonum multiflorum (fo-ti), Polygonum cuspidatum (Japanese knotweed), and Cassia species, typically at concentrations ranging from approximately 0.01–0.5% dry weight depending on plant source, tissue, and extraction method. As a glycosylated anthraquinone, it contains no significant macronutrients (protein, fat, carbohydrate, or fiber) in pharmacologically relevant doses. Key bioactive characteristics: the glucose moiety at the C-8 position increases aqueous solubility relative to free emodin, potentially improving gastrointestinal absorption but also making it a substrate for β-glucosidase-mediated hydrolysis in the gut, which can release free emodin (the aglycone) as an active metabolite. Bioavailability notes: oral bioavailability is considered low to moderate; the compound undergoes extensive first-pass [metabolism](/ingredients/condition/weight-management) including deglycosylation by intestinal microflora and phase II conjugation (glucuronidation and sulfation) in the liver. Plasma concentrations after oral dosing in animal models are typically in the low micromolar range. No vitamins or minerals are associated with this compound. It is consumed not for nutritional value but for its pharmacological properties, including anthraquinone-mediated laxative activity, antiviral effects, PPARα/γ and AMPK pathway activation, 5-HT1B receptor agonism, and [immunomodulatory](/ingredients/condition/immune-support) actions. Typical experimental doses in preclinical studies range from 10–100 mg/kg body weight in rodent models; human-equivalent dosing has not been well established.

## Dosage & Preparation

No clinically studied dosage ranges are available due to the absence of human trials. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Human safety data specific to emodin-8-O-β-D-glucoside are lacking, though its parent compound emodin has demonstrated potential genotoxicity and laxative effects at higher doses in preclinical studies, warranting caution. Due to PPARγ activation, interactions with insulin sensitizers such as thiazolidinediones (e.g., rosiglitazone) are theoretically possible, risking additive hypoglycemic effects. AMPK activation may theoretically potentiate the effects of metformin or other AMPK-targeting agents. Pregnant or breastfeeding individuals should avoid this compound given the absence of safety data and the known concerns surrounding anthraquinone glycosides as a class.

## Scientific Research

No human clinical trials or meta-analyses are available for Emodin-8-O-β-D-glucoside, with research limited to in vitro and animal studies. No PubMed PMIDs are reported for its evaluation in human subjects. [6]

## Historical & Cultural Context

While Emodin-8-O-β-D-glucoside itself is not noted for traditional use, it is found in plants like rhubarb and Reynoutria multiflora, which have historical medicinal applications. Direct historical links to this compound are not established. [3,5]

## Synergistic Combinations

Aloe vera, garden rhubarb, PPARα activators, 5-HT1B agonists, AMPK pathway activators

## Frequently Asked Questions

### What plant sources contain emodin-8-O-β-D-glucoside?

Emodin-8-O-β-D-glucoside is found in plants of the Rheum (rhubarb) and Polygonum genera, including Polygonum multiflorum (He Shou Wu) and Rheum palmatum, which are widely used in traditional Chinese medicine. It occurs as a glycosidic conjugate of the aglycone emodin, with glucose attached at the 8-position, and is typically extracted alongside related anthraquinone glycosides such as physcion-8-O-glucoside.

### How does emodin-8-O-β-D-glucoside differ from emodin?

Emodin-8-O-β-D-glucoside is the glycosylated prodrug form of emodin, with a beta-D-glucose moiety attached at the 8-hydroxyl position, which substantially alters its polarity, bioavailability, and pharmacokinetic profile compared to the free aglycone emodin. The glucoside form typically exhibits lower membrane permeability and may require intestinal or hepatic hydrolysis to release active emodin, potentially moderating its potency and onset of action. This structural difference also influences receptor binding affinity, including at 5-HT1B, where the glycoside and aglycone may differ in activity.

### Does emodin-8-O-β-D-glucoside have antiviral properties?

In vitro studies have reported that emodin-8-O-β-D-glucoside exhibits antiviral activity, with proposed mechanisms including inhibition of viral enzymes and interference with viral replication pathways. However, these findings come exclusively from cell-based assays, and no in vivo animal or human clinical data currently confirm antiviral efficacy at physiologically achievable concentrations. The specific viruses studied and IC50 values vary by study, and extrapolation to therapeutic antiviral use in humans is not yet supported.

### Can emodin-8-O-β-D-glucoside affect blood sugar or metabolism?

Emodin-8-O-β-D-glucoside activates both PPARα, PPARγ, and AMPK pathways, which are established regulators of glucose uptake, fatty acid oxidation, and insulin sensitivity, suggesting a theoretical basis for metabolic effects. Preclinical data on related anthraquinone compounds indicate potential glucose-lowering and lipid-modulating activity, but quantified human data for this specific glycoside are absent. Individuals using antidiabetic medications should exercise caution due to the risk of additive hypoglycemic effects through AMPK and PPARγ co-activation.

### Is emodin-8-O-β-D-glucoside safe to take as a supplement?

There are currently no established safe dosage ranges or formal human safety trials for emodin-8-O-β-D-glucoside as an isolated supplement ingredient. Its parent compound emodin has raised concerns about genotoxicity, nephrotoxicity at high doses, and laxative effects, which may extend to the glycoside form following metabolic hydrolysis. The compound is not recommended for use during pregnancy or breastfeeding, and individuals on serotonergic, antidiabetic, or lipid-lowering medications should consult a healthcare provider before use.

### What is the current state of clinical research on emodin-8-O-β-D-glucoside in humans?

Most evidence for emodin-8-O-β-D-glucoside comes from in vitro and animal model studies, with limited human clinical trials to date. Research has demonstrated promising mechanisms including 5-HT1B agonism, PPARα/γ and AMPK pathway activation, and immunomodulatory effects, but these findings require confirmation through well-designed human studies. The gap between preclinical evidence and clinical efficacy means more research is needed before definitive claims can be made about human health benefits.

### How does emodin-8-O-β-D-glucoside work in the body after ingestion?

Emodin-8-O-β-D-glucoside functions through multiple pathways: it acts as a 5-HT1B agonist to modulate serotonin signaling, activates PPARα/γ receptors involved in metabolism and inflammation, and stimulates AMPK, a key energy-regulating enzyme. Additionally, it demonstrates enzyme inhibition properties and produces immunomodulatory effects that may support immune function. These overlapping mechanisms suggest emodin-8-O-β-D-glucoside affects multiple biological systems simultaneously.

### Does emodin-8-O-β-D-glucoside bioavailability differ when consumed with food or on an empty stomach?

Specific research on emodin-8-O-β-D-glucoside absorption relative to food intake is limited, though its glucoside form suggests it may undergo enzymatic processing in the digestive tract that could be influenced by meal composition. The glycosidic bond structure indicates bioavailability may depend on gut microbiota and digestive conditions, potentially making timing and meal composition relevant factors. Further human studies are needed to establish optimal absorption conditions for this compound.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*